Loading...
XCSE
MONSO
Market cap1mUSD
Apr 07, Last price  
0.19DKK
1D
-12.04%
1Q
-45.71%
IPO
-97.08%
Name

Monsenso A/S

Chart & Performance

D1W1MN
P/E
P/S
1.14
EPS
Div Yield, %
Shrs. gr., 5y
56.48%
Rev. gr., 5y
4.92%
Revenues
11m
+16.01%
1,298,1015,247,6076,423,0007,503,0008,780,0009,063,0007,143,0006,213,0009,624,00011,165,000
Net income
-6m
L+12.02%
-1,186,760-2,662,121-3,361,000-2,087,00024,000-4,713,000-8,153,000-7,854,000-5,357,000-6,001,000
CFO
-7m
L
000-2,499,000-210,0002,906,000-4,383,000-3,390,0002,552,000-7,033,000
Earnings
Apr 29, 2025

Profile

Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, and psychoeducation and cognitive behavioral therapy; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company also provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, messaging, shared decision-making, and notes/medical record keeping; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment. It serves patients, clinicians, healthcare systems and researchers, and carers. Monsenso A/S was incorporated in 2013 and is based in Copenhagen, Denmark.
IPO date
Jun 10, 2020
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,165
16.01%
9,624
54.90%
6,213
-13.02%
Cost of revenue
14,526
15,423
15,029
Unusual Expense (Income)
NOPBT
(3,361)
(5,799)
(8,816)
NOPBT Margin
Operating Taxes
(451)
(544)
(1,100)
Tax Rate
NOPAT
(2,910)
(5,255)
(7,716)
Net income
(6,001)
12.02%
(5,357)
-31.79%
(7,854)
-3.67%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,292
1,475
1,167
BB yield
-15.90%
-9.71%
Debt
Debt current
(868)
Long-term debt
Deferred revenue
Other long-term liabilities
614
536
344
Net debt
(1,861)
(1,812)
(1,554)
Cash flow
Cash from operating activities
(7,033)
2,552
(3,390)
CAPEX
(2,324)
(99)
(5,000)
Cash from investing activities
(2,210)
(2,787)
(4,970)
Cash from financing activities
9,292
1,475
1,167
FCF
(7,009)
(4,294)
(5,733)
Balance
Cash
1,861
1,812
572
Long term investments
114
Excess cash
1,303
1,331
375
Stockholders' equity
14,107
10,873
14,755
Invested Capital
13,475
10,078
13,512
ROIC
ROCE
EV
Common stock shares outstanding
32,102
27,319
Price
0.37
27.34%
0.29
-34.32%
0.44
-63.33%
Market cap
9,277
-22.82%
12,020
-59.37%
EV
7,465
10,466
EBITDA
1,067
(1,395)
(3,997)
EV/EBITDA
Interest
32
112
138
Interest/NOPBT